CDC releases 2002 guidelines for treating STDs: Part I. Diseases characterized by vaginal discharge and PID.
Ressel
Genevieve W
GW
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000175:diagnosis* / Q000188:drug therapy*; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D000292:Pelvic Inflammatory Disease / Q000209:etiology; D012749:Sexually Transmitted Diseases / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D014247:Trichomonas Vaginitis / Q000175:diagnosis / Q000188:drug therapy*; D019522:Vaginal Discharge / Q000209:etiology; D016585:Vaginosis, Bacterial / Q000175:diagnosis / Q000188:drug therapy*
D000890:Anti-Infective Agents; D008795:Metronidazole; D015725:Fluconazole